Abstract
Macroautophagy is an evolutionarily conserved lysosomal-dependent pathway of degradation of several cytoplasmic components, such as misfolded proteins or damaged organelles. This process of cellular self-digestion is involved in a number of physiological processes like survival, differentiation and development. The failure in the normal flow of the autophagic process has been associated with normal brain aging and with late-onset neurodegenerative diseases, including Alzheimers, Parkinsons and Huntingtons diseases. A common characteristic between these disorders is the accumulation of protein deposits composed by aberrant protein aggregates. Also dysfunctional organelles, particularly mitochondria, have been implicated in the pathophysiology of several neurodegenerative diseases. Here we give an overview of the importance of autophagy in brain aging and in age-related neurodegeneration. Furthermore, we will discuss autophagy as a potential therapeutic target to mitigate the adverse effects of aging and age-related diseases on brain function.
Keywords: Aging brain, Alzheimer's disease, autophagy, Huntington's disease, Parkinson's disease, therapeutics
Central Nervous System Agents in Medicinal Chemistry
Title: Targeting Autophagy in the Brain: A Promising Approach?
Volume: 10 Issue: 2
Author(s): R.X. Santos, S. Cardoso, S. Correia, C. Carvalho, M.S. Santos and P.I. Moreira
Affiliation:
Keywords: Aging brain, Alzheimer's disease, autophagy, Huntington's disease, Parkinson's disease, therapeutics
Abstract: Macroautophagy is an evolutionarily conserved lysosomal-dependent pathway of degradation of several cytoplasmic components, such as misfolded proteins or damaged organelles. This process of cellular self-digestion is involved in a number of physiological processes like survival, differentiation and development. The failure in the normal flow of the autophagic process has been associated with normal brain aging and with late-onset neurodegenerative diseases, including Alzheimers, Parkinsons and Huntingtons diseases. A common characteristic between these disorders is the accumulation of protein deposits composed by aberrant protein aggregates. Also dysfunctional organelles, particularly mitochondria, have been implicated in the pathophysiology of several neurodegenerative diseases. Here we give an overview of the importance of autophagy in brain aging and in age-related neurodegeneration. Furthermore, we will discuss autophagy as a potential therapeutic target to mitigate the adverse effects of aging and age-related diseases on brain function.
Export Options
About this article
Cite this article as:
Santos R.X., Cardoso S., Correia S., Carvalho C., Santos M.S. and Moreira P.I., Targeting Autophagy in the Brain: A Promising Approach?, Central Nervous System Agents in Medicinal Chemistry 2010; 10 (2) . https://dx.doi.org/10.2174/187152410791196350
DOI https://dx.doi.org/10.2174/187152410791196350 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
Current Molecular Medicine Nutritional Approaches to Modulate Oxidative Stress in Alzheimers Disease
Current Alzheimer Research Novel Chemotherapeutic Agents - The Contribution of Scorpionates
Current Medicinal Chemistry Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment
Current Signal Transduction Therapy Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
Current Medicinal Chemistry Ferulic Acid-Loaded Lipid Nanostructures as Drug Delivery Systems for Alzheimers Disease: Preparation, Characterization and Cytotoxicity Studies
Current Nanoscience Two Orthogonal Approaches to Overcome Multi-Drug Resistant HIV-1s: Development of Protease Inhibitors and Entry Inhibitors Based on CXCR4 Antagonists
Current Drug Targets - Infectious Disorders Ectodomain Shedding of ACE and ACE2 as Regulators of Their Protein Functions
Current Enzyme Inhibition <i>Larrea tridentata</i> and its Biological Activities
Current Topics in Medicinal Chemistry NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature
Anti-Cancer Agents in Medicinal Chemistry Bacopa monnieri Supplements Offset Paraquat-Induced Behavioral Phenotype and Brain Oxidative Pathways in Mice
Central Nervous System Agents in Medicinal Chemistry The Proteasome in Health and Disease
Current Pharmaceutical Design Novel Implications for Lysophospholipids, Lysophosphatidic Acid and Sphingosine 1-Phosphate, as Drug Targets in Cancer
Anti-Cancer Agents in Medicinal Chemistry Effect of Phosphorylation and Aggregation on Tau Binding to Dna
Protein & Peptide Letters Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases
Current Drug Targets Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer
Current Drug Targets Lipid Nanoparticles as Vehicles for Macromolecules: Nucleic Acids and Peptides
Recent Patents on Drug Delivery & Formulation Estrogen Receptor Neurobiology and its Potential for Translation into Broad Spectrum Therapeutics for CNS Disorders
Current Molecular Pharmacology ABC Transporters as Potential Targets for Modulation of Drug Resistance
Mini-Reviews in Medicinal Chemistry Pathophysiology and Treatment of Diabetic Peripheral Neuropathy: The Case for Diabetic Neurovascular Function as an Essential Component
Current Diabetes Reviews